About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2662578
Allelic
Composition
Chek2tm1Mak/Chek2tm1Mak
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chek2tm1Mak mutation (1 available); any Chek2 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• incidence of 7,12-dimethylbenzanthracene (DMBA)-induced skin tumors is enhanced, however mutants do not develop spontaneous tumors by 1 year of age
• onset of DMBA-induced skin tumors occurs earlier than in wild-type

cellular
• mouse embryonic fibroblasts (MEFs) fail to arrest at G1 at low ionizing radiation (IR) doses but behave normally at higher doses
• mutants exposed to IR radiation exhibit a shorter duration of the G2/M checkpoint in the epidermis than wild-type, with mitosis resuming by 24 hours post-IR
• gamma-irradiated thymic cells show a partial defect in G1/S-phase checkpoint, with a milder G1 arrest than observed in Trp53 and Atm mutants
• cells from thymus, CNS, hair follicles, and fibroblasts are resistant to gamma irradiation-induced apoptosis
• unlike wild-type epidermal cells that show a reduction in proliferation 24 hours post IR irradiation, mutant epidermal cells exhibit no reduction in proliferation

homeostasis/metabolism
• incidence of 7,12-dimethylbenzanthracene (DMBA)-induced skin tumors is enhanced, however mutants do not develop spontaneous tumors by 1 year of age
• onset of DMBA-induced skin tumors occurs earlier than in wild-type


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory